Clinical Trials Directory

Trials / Completed

CompletedNCT03571477

Sleep Apnea : Diagnosis and Monitoring

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

This prospective study aims to evaluate a new medical screening method to detect and discriminate sleep apnea-hypopnea events. A new device called ApneaBand will be tested to propose a new screening method facilitating the diagnosis and monitoring of the sleep apnea syndrom, still underdiagnosed. This device will be tested in comparison with polysomnography (PSG), the gold standard reference method of sleep apnea diagnosis.

Detailed description

The objective of this study is to dertermine the performance of the ApneaBand, a new non-intrusive and portable device, in detecting sleep apnea, in comparison with PSG. 40 apneic and non apneic subjects will wear the ApneaBand recording the different sleep stages and the occurency of apnea-hypopnea sleep events through four sensors including oximetry (oxygen saturation), photoplethysmography (pulse wave), electrodermal activity and tri-axial accelerometer (movements). Inclusion visit will be proceeded at the University Hospital Grenoble-Alpes ; polysomnography and mesures by the ApneaBand will be proceeded at the patient's home by IC@dom. Patients will be equiped with PSG + ApneaBand during the first night and with ApneaBand only the second night.

Conditions

Interventions

TypeNameDescription
DEVICEApneaBandMesure of oxygen saturation (oximetry), pulse wave (photoplethysmography), electrodermal activity and movements (tri-axial accelerometer)

Timeline

Start date
2018-06-15
Primary completion
2018-12-17
Completion
2018-12-17
First posted
2018-06-27
Last updated
2019-01-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03571477. Inclusion in this directory is not an endorsement.